Sage Represents Trecondi® from Medac GmbH: Novel Product for Conditioning in AML and MDS Patients: O
Sage Group is working with medac GmbH who have developed Trecondi®, (Treosulfan), as a superior drug in conjunction with fludarabine...
top of page
Sage Group News
bottom of page